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Abstract: With over 220,000 cases and 180,000 deaths annually, Cryptococcus neoformans is the 
most common cause of fungal meningitis and a leading cause of death in HIV/AIDS patients in 
Sub-Saharan Africa. C. neoformans can either be killed by innate airway phagocytes, or it can 
survive intracellularly. Pulmonary macrophage and dendritic cell (DC) subsets have been 
identified, and we hypothesize that each subset has different interactions with C. neoformans. 
For these studies, we purified murine pulmonary macrophage and DC subsets – alveolar 
macrophages, Ly6C- and Ly6C+ monocyte-like macrophages, interstitial macrophages, CD11b+ 
and CD103+ DCs.With each subset, we examined cryptococcal association, fungicidal activity, 
intracellular fungal morphology, cytokine secretion and transcriptional profiling. Results showed 
that all subsets associate with C. neoformans, but only monocyte-like macrophages inhibited 
growth. In addition, we observed sex differences in antifungal activity - the male Ly6C+ 
monocyte-like macrophages inhibited cryptococcal growth, while the female Ly6C- monocyte-
like macrophages inhibited cryptococcal growth. In addition, cytokine analysis revealed that 
phagocyte polarization is not responsible for the differences in fungicidal activity observed. 
Imaging flow showed differing ratios of cryptococcal morphologies, c-shaped or budding, 
depending on phagocyte subset. RNA sequencing analysis revealed the up regulation and 
downregulation of many genes, including immunological pathways and pathways relating to 
relating to metabolic activity. Future studies gaining a more in-depth understanding on the 
functionality of individual genes and pathways specific to permissive and non-permissive 
pulmonary phagocytes will allow identification of key targets when developing therapeutic 
strategies to prevent cryptococcal meningitis.
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BACKGROUND AND INTRODUCTION 
 
1.1 Ecology  
Cryptococcus neoformans is an encapsulated fungal pathogen which is a part of the phylum 
Basidiomycota (Arras et al., 2017). The phylum Basidiomycota is only one of four fungal phyla 
that contains organisms that have the ability to infect humans based upon four criteria: the ability 
to grow above or at 37C, the ability to digest and absorb components of human tissues, the 
ability to infect internal tissues by circumventing host barriers as well as the ability to withstand 
the human immune system (reviewed in (Kohler, Hube, Puccia, Casadevall, & Perfect, 2017)). 
All 19 species within the Cryptococcus genus are characterized as encapsulated budding yeast 
(Mitchell & Perfect, 1995). Cryptococcus species are spherically shaped yeast and are divided 
into four different distinct serotypes based upon capsular epitopes and their agglutination with 
specific antisera (Ikeda, Shinoda, Fukazawa, & Kaufman, 1982): serotypes A, B, C, and D 
(Franzot, Fries, Cleare, & Casadevall, 1998; Mitchell & Perfect, 1995). These four serotypes are 
further subdivided into two species, C. neoformans and C. gattii (D'Souza et al., 2011; Kwon-
Chung et al., 2017) that make up eight major molecular types: VNI (var. grubii, serotype A), 
VNII (var. grubii, serotype A), VNIII (serotype AD), VNIV (var. neoformans, serotype D), VGI, 
VGII, VGIII, and VGIV (var. gattii, serotypes B and C) (Meyer et al., 2003). C. neoformans is 
distributed worldwide and has been isolated from various
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environmental sources and is strongly associated with pigeon excreta (D. Ellis & Pfeiffer, 1992; 
Kwon-Chung & Bennett, 1984). C. gattii  has been isolated from hollows and decayed wood of 
over 50 species of trees (Lin, Lin, Ho, Chen, & Chung, 2020), with the most notable being its 
specific association with Eucalyptus camaldulensis (D. H. Ellis, 1987; D. H. Ellis & Pfeiffer, 
1990; Kwon-Chung & Bennett, 1984). C. gattii was initially considered to be endemic to tropical 
and subtropical regions until emergence of this pathogen occurred on the west of Canada 
resulting in the Vancouver Island Outbreak (Lam et al., 2019). Since then, the pathogen has 
spread throughout surrounding areas of the Pacific Northwest of the United States resulting in an 
established endemic among healthy residents and travelers (Jamil et al., 2020). 
1.2 Epidemiology and Disease Manifestation 
1.2.1 Epidemiology 
Although the induction of antiretroviral therapy in 2003 has resulted in the decrease in AIDS-
related deaths, the prevalence of cryptococcal infection has relatively remained unchanged (Jarvis 
et al., 2009). C. neoformans has been responsible for causing 223,100 infections and 181,100 
deaths per year worldwide (Rajasingham et al., 2017). C. neoformans is the most common cause 
of central nervous system infections in individuals with HIV/AIDS. (Limper, Adenis, Le, & 
Harrison, 2017). The incidence of cryptococcal infection is prevalent in areas with a high 
frequency of HIV/AIDS infections and within areas that have very limited access to healthcare. 
Of the prevalence rates the majority of causes occur in sub-Saharan Africa (Grahnert et al., 2014; 
Benjamin J. Park et al., 2009; Rajasingham et al., 2017). 
1.2.2 Disease 
C. neoformans infection is known to occur by the inhalation of environmental spores or the 
exposure to desiccated feces of various avian species (Johnston, Voelz, & May, 2016; Zaragoza, 
2019). C. neoformans infection can range from a mild pulmonary infection known as cryptococcal 
pneumonia to a more severe clinical manifestation - cryptococcal meningitis or 
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meningoencephalitis which occurs in immune compromised individuals (Baddley et al., 2008; 
Chayakulkeeree & Perfect, 2006). After inhalation into the lungs, the fungal pathogen encounters 
various components of the human immune system If successful, once C. neoformans evades the 
immune system it has the ability to travel systemically, gain access across the blood brain barrier 
and invade the central nervous system (Feretzaki, Hardison, Wormley, & Heitman, 2014; B. J. Park 
et al., 2009; Zaragoza, 2019). Patients with cryptococcal pneumonia present signs and symptoms 
of clinical pneumonia or upper respiratory infection (as reviewed in (Fisher, Montrief, Ramzy, 
Koyfman, & Long, 2021)). The most severe manifestation of C. neoformans, as a result of its 
dissemination into the central nervous system, is cryptococcal meningitis. Symptoms of 
meningoencephalitis include headache, confusion, elevated intracranial pressure, and in some cases 
blindness and altered mental state (reviewed in (Sloan & Parris, 2014)).  
1.2.3 Treatments 
The best clinical outcomes to treating cryptococcal meningitis are achieved using induction 
treatment with amphotericin B in combination with flucytosine (Day et al., 2013; Hai et al., 2019; 
Molloy et al., 2018). Flucytosine is chemically altered into fluorouracil within the C. neoformans 
yeast cell and acts to inhibit DNA synthesis within the pathogen (Carrillo-Muñoz, Giusiano, 
Ezkurra, & Quindós, 2006; Odds, Brown, & Gow, 2003) Amphotericin B (AmB) binds to 
ergosterol, a component of the cell membrane; once bound, AmB results in a loss of cell 
membrane integrity by the induction of pore formation (Ghaffar, Orr, & Webb, 2019; Peng et al., 
2018). Although the use of AmB is effective, ergosterol is similar in structure to mammalian 
cholesterol and its toxicity toward mammalian erythrocytes and adverse side effects including 
nephrotoxicity and anemia are of great concern (Bicanic et al., 2015; Janout et al., 2015; Legrand, 




1.3 Mechanisms of Immune Evasion 
1.3.1 Capsule 
C. neoformans is surrounded by a thick polysaccharide capsule comprised of two major 
polysaccharides: glucuronoxylomannan (GXM) and galactoxylomannan (GalXM) (Cherniak, 
Jones, & Reiss, 1988; Heiss, Klutts, Wang, Doering, & Azadi, 2009; Zaragoza, 2019). The 
capsule surrounding C. neoformans plays a key role in the pathogen’s virulence; studies show 
when the capsule is absent, virulence greatly decreases (Chang & Kwon-Chung, 1994; Zaragoza, 
2019). The presence of the polysaccharide capsule has been shown to inhibit host cell 
phagocytosis (Bojarczuk et al., 2016; Kozel & Gotschlich, 1982; Kozel & Mastroianni, 1976; 
Macura, Zhang, & Casadevall, 2007). Most host cell macrophage cell surface receptor ligands 
reside within the cell wall of pathogens; C. neoformans thick polysaccharide capsule can mask 
the presence of these cell wall ligands from innate immune cells within the host (Zaragoza, 2019).  
The C. neoformans capsular component GXM induces effects that inhibit antigen presenting cell 
(APC) function (Vecchiarelli, Pietrella, Bistoni, Kozel, & Casadevall, 2002), causes the 
dysregulation of pro-inflammatory and anti-inflammatory cytokine secretion (Lopes et al., 2019; 
Monari et al., 2005), and increases the upregulation of FasL resulting in T Cell apoptosis 
(Piccioni et al., 2011). GalXM, like GXM, induces mirroring immunomodulatory effects such the 
induction of IL-6 in monocytes (Decote-Ricardo et al., 2019), the upregulation of TNF-α in 
peripheral blood mononuclear cells (PBMC) (Chaka et al., 1997), and the induction of T cell 
apoptosis at a rate ~50 times greater than GXM via the activation of caspase 8 (Pericolini et al., 
2006). 
1.3.2 Phagosome Manipulation 
The intracellular nature of C. neoformans allows the fungal pathogen to reside and replicate 
within the macrophage lysosome (De Leon-Rodriguez, Rossi, Fu, Dragotakes, Coelho, Guerrero 
Ros, et al., 2018; Stuart M. Levitz et al., 1999). The polysaccharide capsule of C. neoformans and 
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the pathogen’s ability to produce melanin allows for protection against the reactive oxidative 
species within the lysosome (Cox et al., 2003; Wang, Aisen, & Casadevall, 1995; Zaragoza et al., 
2008). In addition, it has been shown that C. neoformans can delay phagolysosome maturation by 
interfering with the acquisition of critical phagosome maturation markers consisting of Rab 
GTPases and blocking acidification of the phagosome (Smith, Dixon, & May, 2015). 
1.4 Murine Pulmonary Macrophages with Cryptococcus neoformans 
Innate immune cells serve as the first line of defense against invading airway pathogens (Cheung, 
Halsey, & Speert, 2000; De Leon-Rodriguez, Rossi, Fu, Dragotakes, Coelho, Ros, et al., 2018; 
Espinosa & Rivera, 2016; Lloyd & Marsland, 2017; Margalit & Kavanagh, 2015). It is 
recognized that macrophages residing within tissue, tissue resident macrophages, are derived 
from diverse progenitors, including embryonic origins and terminally differentiated circulating 
monocytes (Epelman, Lavine, & Randolph, 2014; C. Zhang, Yang, & Ericsson, 2021). In the 
mouse lung, macrophages are recruited to the lung tissue during a cryptococcal infection 
(Wozniak et al., 2009; Wozniak, Vyas, & Levitz, 2006). Over the years, many studies have 
examined the role of murine pulmonary macrophages in response to Cryptococcus (S. Arora, 
Olszewski, MA, Tsang, TM, McDonald, RA, Toews, GB, Huffnagle, GB, 2011; Chen et al., 
2016; Feldmesser, Kress, Novikoff, & Casadevall, 2000; Hardison et al., 2010; Kawakami et al., 
1994; Kechichian, Shea, & Del Poeta, 2007; C.M. Leopold Wager, 2014; C. M. Leopold Wager, 
2015; Osterholzer, Chen, et al., 2009; Stepanova et al., 2018). Depending on the strain of mouse 
used for the model, the infecting strain of Cryptococcus, and even the inoculum used, different 
laboratories have drawn different conclusions.  
C. neoformans can be a facultative intracellular pathogen in vitro, and in vivo it can sometimes be 
found intracellularly inside of macrophages in infected tissues (Hardison et al., 2010), or 
alternatively, macrophages can kill C. neoformans (De Leon-Rodriguez, Rossi, Fu, Dragotakes, 
Coelho, Ros, et al., 2018; Feldmesser et al., 2000; S. M. Levitz et al., 1999). Therefore, 
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macrophages are a major determinant of the outcome of a cryptococcal infection (Alanio, 
Desnos-Ollivier, & Dromer, 2011; Johnston et al., 2016; Kechichian et al., 2007; C. M. Leopold 
Wager, 2015; Mansour, Vyas, & Levitz, 2011; Sabiiti et al., 2014; Shao et al., 2005; Tenor, 
Oehlers, Yang, Tobin, & Perfect, 2015). In immunocompromised individuals, uncontrolled fungal 
pneumonia is followed by lethal dissemination to the CNS (Baddley et al., 2008; Olszewski, 
Zhang, & Huffnagle, 2010; B. J. Park et al., 2009). The ability of macrophages to contain a 
Cryptococcus infection is dependent upon the specific type of macrophage activation (S. Arora et 
al., 2005; Davis et al., 2013; Hardison et al., 2010; Muller et al., 2007; Osterholzer, Chen, et al., 
2009; Osterholzer et al., 2011; Voelz, Lammas, & May, 2009; Y. Zhang et al., 2009). 
During murine infections, macrophage-cryptococcal outcomes are dependent upon M1/M2 
(classical/alternative) macrophage polarization pathways (reviewed in (C. M. Leopold Wager & 
Wormley, 2014)); however, macrophage polarization status is constantly in flux and influenced 
by cytokines in the microenvironment (Davis et al., 2013). Classically activated macrophages 
(M1) are induced by IFN- and are associated with reduced fungal burden, enhanced fungicidal 
activity and the resolution of lung tissue inflammation. This is opposed to their alternatively 
activated (M2) counterparts (Davis et al., 2013; Hardison et al., 2010; C.M. Leopold Wager, 
2014; C. M. Leopold Wager, 2015), which are associated with being a reservoir for replicating 
cryptococci (Hardison et al., 2010; Muller et al., 2007). STAT1 dependent activation pathways 
are essential for M1 polarization as well as for C. neoformans fungicidal activity via the 
production of nitric oxide (Hardison et al., 2012; Hardison et al., 2010; C.M. Leopold Wager, 
2014; C. M. Leopold Wager, 2015). Infection of STAT1 KO mice and STAT1 conditional KO 
mice using an IFN- producing strain of C. neoformans resulted in increased fungal burden, 
increased M2 activation, and reduced anti-cryptococcal activity compared to WT mice (Hardison 
et al., 2012; C.M. Leopold Wager, 2014; C. M. Leopold Wager, 2015; C. M. Leopold Wager et 
al., 2018).  
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Classically activated macrophages produce large amounts of nitric oxide, a main effector 
mechanism contributing to anti-cryptococcal activity (Hardison et al., 2012; Hardison et al., 2010; 
C.M. Leopold Wager, 2014; C. M. Leopold Wager, 2015; Y. Zhang et al., 2010; Y. Zhang et al., 
2009). Pulmonary macrophages isolated from mice deficient in iNOS, an enzyme necessary for 
nitric oxide production, display increased intracellular cryptococcal replication (C. M. Leopold 
Wager, 2015). In the murine lung environment, response to a C. neoformans infection results in a 
fluctuating Th1/Th2 T cell cytokine response over time (S. Arora, Olszewski, MA, Tsang, TM, 
McDonald, RA, Toews, GB, Huffnagle, GB, 2011). A higher IL-4/IFN- ratio contributes to a 
greater polarization towards the M2 phenotype, whereas a lower IL-4/IFN- ratio contributes to a 
greater polarization towards the M1 phenotype. Equal amounts of IL-4/IFN- lead to an M1/M2 
intermediate macrophage phenotype that may support chronic “steady-state” fungal infections  (S. 
Arora, Olszewski, MA, Tsang, TM, McDonald, RA, Toews, GB, Huffnagle, GB, 2011). 
Intracellular cryptococcal replication in murine alveolar macrophages induces phagolysosome 
damage. However, once the cells are polarized to the M1 phenotype via stimulation with IFN-, 
the macrophages can successfully kill C. neoformans, and the ability for the pathogen to induce 
phagolysosome damage is abolished (Davis et al., 2015). While these findings relate to 
macrophage activation status, the initial interactions between lung macrophages (prior to 
activation to either the M1 or M2 phenotype) with Cryptococcus are currently unknown. This 
may be due to the presence of multiple macrophage subsets present in the lung (Vermaelen & 
Pauwels, 2004) (Gautier et al., 2012; Gibbings et al., 2017; Misharin, Morales-Nebreda, Mutlu, 
Budinger, & Perlman, 2013; Tan & Krasnow, 2016; Zaynagetdinov et al., 2013) and our lack of 
knowledge in understanding the role(s) of each subset with C. neoformans. 
1.5 Murine Pulmonary Macrophage Populations 
The murine pulmonary cavity consists of a heterogeneous population of macrophages which were 
identified by flow cytometry and gene expression profiling (Gautier et al., 2012; Gibbings et al., 
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2017; Misharin et al., 2013; Tan & Krasnow, 2016; Vermaelen & Pauwels, 2004; Zaynagetdinov 
et al., 2013). The distinct populations were identified as: alveolar macrophages, interstitial 
macrophages, monocyte-like Ly6C+ macrophages and monocyte-like Ly6C- macrophages, each 
expressing unique cell surface markers (Misharin et al., 2013; Zaynagetdinov et al., 2013) as 
shown in table 1. Alveolar macrophages are defined as CD11c+, CD11b-, F4/80+, SiglecFhi, 
CD68hi, and interstitial macrophages are F4/80+, CD11b+, Cd11clo, Gr1-, and MHC II+. 
Monocyte-like Ly6C- macrophages are F4/80+, CD11b+, Cd11c-, Gr1lo, CD14+, MHC II-, and 
Ly6C-,  while the monocyte-like Ly6C+ macrophages have the same markers but are Ly6C+ 
(Guilliams et al., 2013; Manfred Kopf, Schneider, & Nobs, 2014; Misharin et al., 2013; 
Zaynagetdinov et al., 2013). Although each population has not been extensively studied with C. 
neoformans, murine alveolar macrophages and interstitial macrophages have been examined.  













CD45 + + + + + + 
CD11b - + + + - + 
CD11c + lo +/- +/- + + 
CD68 hi lo - - hi hi 
MHC II +/- + - - + + 
Siglec F hi - - - - - 
F4/80 + + + + - - 
CD14 - lo   - - 
CD24 - - - - + + 
CD103 - - - - + - 
Ly6c - - + - - - 
Ly6G - -   - - 
CD115 - - - - - - 
CCR2 - - + + - -/+ 
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Murine pulmonary macrophages/monocytes are divided into 4 subsets and pulmonary 
conventional DCs are divided into 2 subsets based on cell surface expression of multiple markers. 
Symbols within table are defined as the following: hi = high expression, lo = low expression, + = 
positive, - = negative, +/- = intermediate expression. (Gibbings et al., 2017; Guilliams et al., 
2013; Hey, Tan, & O'Neill, 2016; M. Kopf, Schneider, & Nobs, 2015; Menezes et al., 2016; 
Misharin et al., 2013; Nelson, Hawkins, & Wozniak, 2020; Yang, Zhang, Yu, Yang, & Wang, 
2014; Zaynagetdinov et al., 2013). 
1.5.1 Murine Alveolar Macrophages 
Murine alveolar macrophages are the first line of defense against inhaled pulmonary pathogens 
(Todd et al., 2016; Xu & Shinohara, 2017). Alveolar macrophages are tissue resident 
macrophages of the alveoli that are derived during early fetal development from either the fetal 
yolk sac or fetal liver (reviewed in (Hoeffel et al., 2015; Manfred Kopf et al., 2014)). During 
early developmental stages, fetal monocytes colonize embryonic lungs, and upregulate surface 
expression of Siglec F and CD11c, and develop into tissue resident alveolar macrophages 
(Guilliams et al., 2013). After inhalation and phagocytosis of C. neoformans, alveolar 
macrophages showed intracellular replication of the fungus followed by macrophage cell lysis 
and the expulsion of live yeast cells into the extracellular space (Feldmesser et al., 2000). 
Alternatively, in some instances C. neoformans can replicate within macrophages and then escape 
via non-lytic expulsion or vomocytosis (Alvarez & Casadevall, 2007; Ma, Croudace, Lammas, & 
May, 2006). In mice lacking NK cells and T cells infected with a glucosylceramide deficient 
cryptococcal strain, Δgcs1, depletion of alveolar macrophages by clodronate liposomes improved 
mouse survival and decreased the dissemination of C. neoformans to the central nervous system. 
This suggests that the alveolar macrophages were involved in the dissemination of C. neoformans 
(Kechichian et al., 2007). A more recent study examined murine alveolar macrophage 
polarization following infection with high- and low-uptake clinical C. neoformans isolates and 
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showed that the alveolar macrophages from mice infected with the high-uptake strains had 
increased expression of M2-associated genes (Arg1, Fizz1, Il13 and Ccl17), while those from 
mice infected with the low-uptake strains had increased expression of M1-associated genes 
(Nos2, Ifng, Il6, Tnfa, Mcp1, Csf2, Ip10) (Hansakon, Mutthakalin, Ngamskulrungroj, 
Chayakulkeeree, & Angkasekwinai, 2019), suggesting that cryptococcal strains may influence 
macrophage polarization.  
1.5.2 Murine Interstitial Macrophages 
Although few studies have examined murine interstitial macrophages, one study showed that 
interstitial macrophages harbored intracellular C. neoformans following intratracheal 
administration (Santangelo et al., 2004). In addition, the transfer of infected pulmonary interstitial 
macrophages, that were collected by agitating extracted lung tissue with sterile 5-mm diameter 
glass beads and morphologically characterized by Giemsa-stained smears and flow cytometry, 
into recipient mice via the tail vein led to hematogenous dissemination of C. neoformans to the 
brain (Santangelo et al., 2004). 
1.5.3 Murine Inflammatory Monocytes 
Murine inflammatory monocytes, Ly6c+ and Ly6c- monocytes, are precursors to macrophages 
and DCs that are recruited to the site of infection, and these cells express the chemokine receptor 
CCR2 (reviewed in (Murray, 2018). In some studies, inflammatory monocytes seem to be 
important in cryptococcal clearance. Cryptococcal infection of CCR2-/- mice leads to Th2-type 
responses, increased lung fungal burden, and decreased recruitment of macrophages and DCs 
compared to WT mice (Osterholzer, Chen, et al., 2009; Osterholzer et al., 2011; Osterholzer et 
al., 2008; Traynor, Kuziel, Toews, & Huffnagle, 2000). In addition, in mice infected with C. 
neoformans, Ly6Chi CCR2+ monocytes are recruited and can differentiate into fungicidal 
macrophages and DCs (Osterholzer et al., 2011; Osterholzer et al., 2008). Interestingly, a recent 
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study showed inflammatory monocytes are rapidly recruited to the lung during cryptococcal 
infection, but depletion of these cells leads to improved host survival, reduced pulmonary fungal 
burden, and reduced dissemination (Heung & Hohl, 2019). These cells also upregulate genes 
involved in M2 macrophage polarization, suggesting that in this model, the inflammatory 
monocytes differentiate into M2 macrophages, leading to a more severe outcome during 
cryptococcal infection (Heung & Hohl, 2019). 
1.5.4 Murine pulmonary dendritic cells with Cryptococcus neoformans 
Dendritic cells (DCs) play an important role in controlling Cryptococcus infections (reviewed in 
(Wozniak, 2018)). DCs are recruited to the murine lung during a cryptococcal infection (Wozniak 
et al., 2006), and in a protective model of cryptococcal infection, more DCs are recruited to the 
lungs in protected mice compared to non-protected mice, suggesting an anti-cryptococcal role for 
DCs (Wozniak et al., 2009). Following DC-cryptococcal interactions, DCs mediate the adaptive 
immune response by presentation of antigen to Cryptococcus-specific T cells (Wozniak et al., 
2006). The depletion of pulmonary DCs, via the administration of diphtheria toxin (DT) to 
transgenic (Tg) mice, leads to increased morbidity and mortality as well increased B cell and 
neutrophil accumulation which causes severe lung inflammation (Osterholzer, Milam, et al., 
2009).  
1.5.5 Murine pulmonary dendritic cell populations 
In the murine lung, DCs are a heterogeneous population consisting of distinct subsets 
characterized by extracellular and intracellular markers (Condon, Sawyer, Fenton, & Riches, 
2011; Misharin et al., 2013; Shortman & Liu, 2002; Zaynagetdinov et al., 2013). This 
heterogeneous population consists of the CD11b+ myeloid DCs, plasmacytoid DCs (pDCs) and 
CD103+ DCs (Condon et al., 2011). CD11b+ DCs are characterized by their high expression of 
CD11c, MHC class II, and absence of CD103. pDCs are characterized by expression of CD11c, 
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B220 and PDCA-1. Finally, CD103+ DCs are characterized by their expression of CD103, 
CD11c, MHC class II and their lack of CD11b (Sung et al., 2006). Anatomically, the CD103+ 
population localizes in the lung mucosa and along the lung vascular wall, however, few studies 
have examined these subsets in greater detail. CD11b+ DCs are located mainly within the 
perivascular regions and are major producers of chemokines during homeostatic and 
inflammatory conditions of the lung (Beaty, Rose, & Sung, 2007; Furuhashi et al., 2012; Sung et 
al., 2006). Pulmonary plasmacytoid DCs (pDCs) infiltrate into the lungs during cryptococcal 
infection, and pDCs isolated from murine bone marrow have anti-cryptococcal activity (C. R. 
Hole et al., 2016). The recognition and uptake of C. neoformans by pDCs is dependent on 
expression of dectin-3 and the chemokine receptor CXCR3, and the fungicidal activity of pDCs is 
attributed to the production of reactive oxygen species (ROS) within the lysosome (C. R. Hole et 
al., 2016).  
1.6 Objective and Aim of Study 
 
Currently, there are no published data that provides an in-depth analysis of individual pulmonary 
phagocyte subsets and their initial interactions with C. neoformans. Thus, the overall objective of 
this study is to provide a detailed look into this interaction with an aim of determining if 
pulmonary phagocyte subsets interact differently with C. neoformans and to identify potential 
factors leading to said differences. Our central hypothesis is that murine pulmonary phagocyte 
subsets interact differently with C. neoformans resulting in either fungicidal activity or supporting 
an environment inducive to intracellular cryptococcal growth. In order to test our central 
hypothesis, we utilized a mouse model to isolate and purify six pulmonary phagocyte subsets and 






MATERIALS AND METHODS 
 
2.1 Strains and media 
C. neoformans strains H99 (Serotype A, mating type ) and mCherry producing strain 
KN99mCH (serotype A, KN99 mating type ), a kind gift from Dr. Jennifer Lodge (Washington 
University, St. Louis, MO), were recovered from 15% glycerol stocks, stored at -80C prior to 
use in this study. Strains were maintained on yeast peptone dextrose (YPD) media agar plates. 
Yeast cells were grown for 18h at 30°C while shaking in YPD broth and collected by 
centrifugation, After the cells were washed three times with sterile phosphate-buffered saline 
(PBS), and viable yeast quantified using trypan blue dye exclusion on a hemocytometer before 
being diluted to the appropriate concentration for each particular assay. 
2.2 Mice 
Male and female BALB/c mice, approximately 5-6 weeks of age (Charles River Laboratories, 
Wilmington, MA) were used throughout these studies and were housed at Oklahoma State 
University Animal Resources. All studies were approved by Oklahoma State University’s 




2.3 Collection of murine pulmonary cells and tissue 
2.3.1 Alveolar Macrophage Collection 
Prior to euthanasia, mice were intravenously injected with anti-CD45 FITC (25ug/mL) (BD 
Biosciences, Franklin Lakes, NJ) diluted in PBS without calcium and magnesium 4-5 minutes 
prior to sacrifice in order to tag intravascular leukocytes within systemic circulation and separate 
these from pulmonary extravascular mononuclear phagocytes (Gibbings & Jakubzick, 2018). 
Mice were then euthanized via CO2 inhalation followed by cervical dislocation. After 
euthanizing, the mouse trachea was exposed by making a vertical midline incision. A sterile 18-
gauge cannula was inserted horizontally within the trachea with an attached syringe containing 1 
ml sterile ice-cold PBS + 0.5% EDTA. The lungs were then lavaged three times with this solution 
to collect the bronchoalveolar lavage fluid (BAL), which was pooled into a sterile tube kept on 
ice.  
2.3.2 Tissue macrophage and dendritic cell collection 
For collection of lung tissue macrophages and dendritic cells, following collection of BAL, lungs 
were removed using aseptic technique, minced, and placed into digestion buffer (RPMI with 
0.1mg/ml collagenase type IV (Sigma-Aldrich, St. Louis, MO). Tissues were enzymatically 
digested at 37°C for 30 min in 10 ml of digestion buffer. Following incubation, the digested 
tissues were then successively filtered through sterile 70- and 40-μm nylon filters (BD 
Biosciences) to enrich for leukocytes, and then cells were washed with sterile Hank’s Balanced 
Salt Solution (HBSS). Erythrocytes were lysed by incubation in RBC lysis buffer (eBioscience, 
San Diego, CA) for 3 min on ice followed by a 2-fold excess of PBS. 
2.4 Purification of Pulmonary Macrophage and Dendritic Cell Subsets 
Alveolar macrophages were purified from a single cell suspension of BAL. Cells were enriched 
for alveolar macrophages first by blocking Fc receptors using purified rat anti-mouse 
CD16/CD32 (Mouse BD Fc block) (BD Biosciences) followed by positive selection using anti-
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CD11c microbeads according to manufacturer’s instructions (Miltenyi Biotec, Auburn, CA). 
Purity was verified using Labeling Check Reagent conjugated to VioBlue (Miltenyi Biotec) and 
CD11c and F4/80 fluorescently labeled antibodies by flow cytometry flow cytometry using an 
Acea Novocyte flow cytometer (Agilent Technologies, Santa Clara, CA), and purity above 95% 
was routinely achieved.  
For purification of pulmonary tissue macrophages (interstitial macrophages, Ly6C+ monocyte-
like macrophages, and Ly6C- monocyte-like macrophages) and tissue DCs (CD11b+ and 
CD103+), Fc receptors were first blocked using Fc block (BD Biosciences). Next, FITC-labeled 
CD45+ cells from the vasculature were removed using anti-FITC microbeads (Miltenyi Biotec). 
Following the removal of these cells, remaining cells were first selected (positively or negatively) 
by incubation with anti-CD11c microbeads (Miltenyi Biotec). Cells positively selected with 
CD11c were saved for further DC separations, while cells negatively selected were next 
positively selected using anti-F4/80 microbeads (Miltenyi Biotec) to select for macrophage 
subsets. The macrophage populations were next incubated with anti-MHC II microbeads 
(Miltenyi Biotec) – those positively selected are interstitial macrophages, while those negatively 
selected were subjected to further incubation with biotinylated anti-Ly6c antibody (Invitrogen, 
Waltham, Massachusetts) followed by selection with anti-biotin microbeads (Miltenyi Biotec) to 
distinguish Ly6c+ monocyte–like macrophages (positively selected) from Ly6c- monocyte-like 
macrophages (negatively selected). For DC purification, the CD11c+ cells were then incubated 
with anti-F4/80 microbeads (Miltenyi Biotec) to remove any contaminating macrophages. The 
CD11c+ F4/80- cells were then incubated with anti-CD11b microbeads (Miltenyi Biotec). Cells 
positively selected with CD11b were CD11b+ dendritic cells. Negatively selected CD11b cells 
(CD11c+ CD11b-) were then incubated with biotinylated anti-CD103 antibody (BD Biosciences) 
followed by selection with anti-biotin microbeads (Miltenyi), and positively selected cells were 
CD103+ dendritic cells. Cell purity of each population was verified by using Labeling Check 
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Reagent (Miltenyi Biotec), and cell surface markers for each subset and analyzed by flow 
cytometry using an Acea Novocyte flow cytometer (Acea Biosciences, San Diego, CA). The cell 
separation scheme is summarized in Figure 1.  
2.5 Flow Cytometry 
Following cell separation, murine macrophage and DC subsets were resuspended in FACS buffer 
(PBS supplemented with 2% FBS) (100ul/well) and incubated with CD16/CD32 (Mouse BD Fc 
Block) (BD Biosciences) to block non-specific binding. Then, samples were stained with labeling 
check reagent (Miltenyi Biotec), CD45-APC/APC-Vio770 (Biolegend), CD11c-PE-Cy7 (BD 
Biosciences), Siglec F-PerCP-efluor (BD Biosciences), CD11b-FITC (BD Biosciences), F4/80-
PE (Miltenyi Biotec), Ly6c-APC (BioLegend), MHC II-Superbright 645 (Invitrogen), CD103-
PerCP-efluor (BD Biosciences) CD24-APC (BioLegend) a viability dye (LIVE/DEAD Fixable 
yellow, Invitrogen). Following this, cells were incubated with antibodies for 30 minutes at 4C 
then washed three times with FACS buffer and fixed with 2% formaldehyde. Samples were 
analyzed on an Acea Novocyte 3000 flow cytometer (Agilent Technologies), and data were 
analyzed using NovoExpress software (Agilent Technologies). 
2.6 Cryptococcal inhibition assay 
Each subset of pulmonary macrophages or DCs were separated (as described above), and 2x105 
cells/ml of each subset were incubated with 1µg/ml anti-GXM antibody (kind gift from Tom 
Kozel, University of Nevada Reno) and 1x104 cells/ml of C. neoformans strain H99 (20:1 ratio) in 
100 µl in triplicate wells for 24 hours at 37°C, 5% CO2. After 24 hours, the samples were 
centrifuged, and supernatants were removed. Macrophages were lysed for 15 minutes at room 
temperature using 100 µl sterile water. Samples were then serially diluted and plated on YPD 





2.7 Cryptococcal association assay 
Each subset of pulmonary macrophages or DCs were separated (as described above), and 2x105 
cells/ml of each phagocyte subset were incubated with 1µg/ml anti-GXM antibody (Tom Kozel, 
University of Nevada Reno) and 1x104 cells/ml of C. neoformans strain KN99mCherry (20:1 
ratio) in 100 µl in triplicate wells for 2 hours at 37°C, 5% CO2. After 2 hours, the samples were 
stained for cell surface markers (as described in Flow Cytometry methods) and the percent 
association of each subset with fluorescent C. neoformans was calculated using an Acea 
Novocyte 3000 flow cytometer and Novoexpress software (Acea Biosciences).  
2.8 Imagestream Imaging Flow Cytometry 
Murine phagocyte subsets were isolated as described above and 2x105 cells/ml of each phagocyte 
subset were incubated with 1µg/ml anti-GXM antibody (Tom Kozel, University of Nevada Reno) 
and 2x105 cells/ml C. neoformans strain Kn99mCherry (1:1 ratio) in 100 µl in triplicate wells for 
2 hours at 37°C, 5% CO2. Cells were stained with the following fluorophores: CD45-FITC/PerCP 
(BD Biosciences), MHC II-Alexa Fluor 488 (BD Biosciences), F4/80-PE (Invitrogen), CD103-
PE (Invitrogen), CD11b-PE (Invitrogen), Siglec F-PE (BD Biosciences), Ly6c-PerCP-Cy5.5 
(Novus Biologicals), CD11c-PerCP-Cy5.5(BD Biosciences) for 30 min at 4C. Cells were 
washed three times with FACS buffer, followed by fixation with 1% ultrapure paraformaldehyde 
diluted with FACS buffer. Cells were analyzed in the in the Flow and Image Cytometry 
Laboratory at The University of Health Sciences Center (OUHSC, Oklahoma City, OK) using the 
Amnis Imagestream Mark II (Luminex, Austin, TX). Using the Amnis IDEAS 6.2 software 
(Luminex), the internalization masking feature was used and cells were selected based upon the 
internalization of KN99mCherry. Of the cells selected, 100 cells were quantified and analyzed for 
cryptococcal intracellular morphologies consisting of condensed (c-shaped), live, budding and 
debris. After quantification, percent killing of all subsets were calculated by total cells out of 100 
that contained condensed (c-shape) cryptococcal cells and cryptococcal debris multiplied by 100.    
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2.9 Murine Macrophage and Dendritic Cell Subset Cytokine Analysis 
Each subset of pulmonary macrophages or DCs were separated (as described above), and 2x105 
cells/ml of each phagocyte subset were incubated with 1µg/ml anti-GXM antibody and 1x104 
cells/ml C. neoformans strain H99 (20:1 ratio) in 100 µl in triplicate wells for 2 hours at 37°C, 
5% CO2. Cell supernatants were collected, and protease inhibitor (Thermo Scientific) was added 
to supernatants. Treated supernatants were placed in tubes and stored at -80 C until analysis.  
Supernatants were assayed for mouse cytokines/chemokines according to manufacturer’s 
instructions (Bio-Plex Pro Mouse Cytokine 23-plex) and samples were read on a BioRad 
BioPlex®-200 (Bio-Rad, Hercules, CA). Data were analyzed using GraphPad Prism v5.0 
(GraphPad Software, San Diego, CA). 
2.10 RNA Sequencing of Phagocyte Subsets Following Interaction with C. neoformans 
Following incubation of each macrophage or DC subset with C. neoformans strain H99 at a ratio 
of 20:1 and 1µg/ml anti-GXM antibody at 37C, 5% CO2 for 2h, cells were collected and stored 
in Trizol (Invitrogen) at -20C until analysis. RNA purification was conducted by Novogene 
(Novogene Corp, Sacramento, CA). Next, murine RNA-sequencing was conducted using 
SMARTer Stranded V2 library prep and samples were sequenced on the Illumina Platform 
(PE150 Q30≥80%) (Novogene Corp). Gene expression was compared between each macrophage 
and DC subset alone and when incubated with C. neoformans strain H99. Significant differences 
within gene expression were calculated using readcount adjusted by trimmed mean of M-values 
(TMM), then differential significant analysis was performed using the edgeR package 
(Bioconductor, Fred Hutchinson Cancer Research Center, Seattle, WA) within R Studio 
(Delaware Public Benefit Corporation (PBC), Boston, MA), with the significant criterion being 
both qvalue < 0.005 and |log2(FoldChange)| > 1. Genes with significantly different expression 
values were grouped into signaling pathways using KEGG Pathway Analysis and Ingenuity 
Pathway Analysis (IPA) software.  
19 
 
2.11 Statistical analysis 
GraphPad Prism v5.0 (GraphPad Software, San Diego, CA) was used to detect significant 
differences between CFU of H99 alone compared to each test group within the cryptococcal 
inhibition assay by an unpaired two-tailed T test with a 95% confidence value with a p-value 
consisting of p < 0.05. An XY correlation analysis was used to determine correlation between 
CFU and percent interstitial macrophages. Differences in fungal/phagocyte association were 
tested using one-way ANOVA with Tukey’s post-test, with significant differences defined as p 
<0.05. IDEAS 6.2 software (Luminex Corporation, Austin, TX), was used to analyze and 
quantify intracellular cryptococcal morphologies out of a total of 100 phagocytes per subset. 
Significant differences in intracellular cryptococcal morphology and total cryptococcal killing 
was calculated with GraphPad Prism using an unpaired two-tailed T test with a 95% confidence 
value with a p-value consisting of p < 0.05. Significant differences within gene expression were 
calculated using sequencing readcount adjusted by the trimmed mean of M-values performed 
using the edgeR package (Bioconductor). Gene significance criterion was determined using both 
q-value <0.005 and |log2(FoldChange)| > 1. Genes with significantly different expression values 
were grouped into signaling pathways using KEGG Pathway Analysis. Cytokines were analyzed 
using Column Statistics with the use of GraphPad Prism. Significance was determined using an 









3.1 Murine pulmonary phagocyte subsets exhibit varying fungicidal activity  
To evaluate the fungicidal activity of phagocyte subsets within the murine pulmonary cavity, 
subsets of pulmonary macrophages (alveolar, interstitial, Ly6C- monocyte-like and Ly6C+ 
monocyte-like) and conventional DCs (CD11b+ and CD103+) were separated (Figure 1) and used 
in anti-cryptococcal assays. In preliminary studies using murine alveolar and pulmonary lung 
tissue macrophages, both alveolar macrophages and the lung tissue macrophage population 
displayed a difference in fungicidal activity. Statistical analysis revealed that there was a 
significant decrease (p < 0.05) in the amount of cryptococcal growth (CFU/ml) when analyzing 
the alveolar macrophage population as compared to the C. neoformans lab strain H99 growth 
control but there was no significant difference found when analyzing the lung tissue macrophage 
population (Figure 2a). The lung tissue phagocyte population exhibited a variable range of anti-
cryptococcal activity which led to the further division of phagocyte subsets in subsequent 
experiments. Next, we proceeded to evaluate the monocyte-like macrophage populations as 
shown in Figure 2b. There was a significant decrease (p < 0.05) in the amount of cryptococcal 
growth (CFU/ml) when C. neoformans was incubated with the monocyte-like macrophages 
compared to the growth of C. neoformans strain H99 alone. In addition, there were no significant 




 interstitial macrophage population as compared to the H99 growth control, as shown in figure 2b, 
Next, the monocyte-like macrophage population was further subdivided into two populations: 
Ly6c- and Ly6c+ monocyte-like macrophages following the separation scheme as shown in Figure 
1. The fungicidal activity of these two populations were assessed as shown in Figure 3a. 
Statistical analysis revealed that there was no significant difference in antifungal activity 
following incubation of C. neoformans with either Ly6c- or Ly6c+ monocyte-like populations as 
compared to C. neoformans strain H99 alone. In addition, there were no significant differences 
found in both the alveolar macrophage population and the interstitial macrophages as compared 
to the H99 growth control. In order to eliminate sex as a biological variable, experiments were 
performed in both male and female mice. However, we noticed differences in these data, so the 
data were stratified by sex. Male Ly6C+ monocyte-like macrophages showed a trend towards 
inhibiting the growth of C. neoformans, although this was not statistically different (p=0.28) 
(Figure 3b), while the female Ly6C- monocyte-like macrophages significantly inhibited 
cryptococcal growth (p=0.03) compared to C. neoformans grown in media alone (Figure 3c). 
These results demonstrate that murine pulmonary phagocyte subsets interact differently with C. 
neoformans and the sex of the host could determine disease severity. Next, we proceeded to 
evaluate the fungicidal activity of two pulmonary dendritic cell populations: CD11b+ and 
CD103+. As shown in Figure 4a, the dendritic cell (DC) populations were isolated and purified 
following a similar procedure as with the macrophage populations (Figure 1). When pulmonary 
DC subsets (CD11b+ and CD103+ DCs) were assayed for the fungicidal activity, there were no 
significant differences in cryptococcal growth following incubation with both CD103+ and 
CD11b+ DC subsets as compared to the C. neoformans strain H99 alone (Figure 4a). Within the 
two pulmonary dendritic cell sub-populations CD11b+ and CD103+, the male CD11b+ population 
exhibited significant inhibition of cryptococcal growth (figure 4b), while the female dendritic cell 




neoformans strain H99 (figure 4c). These results demonstrate that murine pulmonary phagocyte 
subsets interact differently with C. neoformans and the sex of the host could determine disease 
severity. 
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Figure 1. Purification of Murine Tissue Macrophage and Dendritic Cell Subsets 
Following lung tissue collagenase digestion, labeled CD45+cells from the circulation are 
removed, and tissue macrophage and dendritic cell subsets were separated using a series of 
magnetic separations. Lung tissue is pooled from 20 mice, collagenase digested, then separated 













Figure 2. Murine pulmonary macrophage subsets interact differently with C. neoformans. 
Murine pulmonary phagocyte subsets interact differently with C. neoformans. Pulmonary 
phagocytes were purified from BALB/c mice and incubated with C. neoformans strain H99 for 
24hrs at a ratio of 20:1. Macrophages were lysed and plated on YPD agar and CFUs were 
counted. Graph (a) shows CFU counts in CFU/mL following C. neoformans strain H99 
incubation alone (H00), with alveolar macrophages (AM) and with lung tissue phagocytes 
(Lung). Inoculum indicates initial C. neoformans strain H99 concentration prior to incubation. 
Graph (b) shows CFU counts in CFU/mL following C. neoformans strain H99 incubation alone 
(H99), with alveolar macrophages (AM), with interstitial macrophages (IM) and monocytes 




























two tailed unpaired t test was performed with each phagocyte population compared to 
cryptococcal growth of the C. neoformans H99 control group. Significant differences shown in 




































































Figure 3. Murine pulmonary macrophage subsets exhibit differing anti-cryptococcal 
capabilities dependent upon sex. Pulmonary macrophage subsets were purified from both male 
and female BALB/c mice and incubated with C. neoformans strain H99 for 24hrs at 37°C, 5% 
CO2 at a ratio of 20:1. Macrophages were lysed and plated on YPD agar and CFUs were counted. 
Graph (a) shows CFU counts in CFU/ml from both male and female phagocyte populations 
following C. neoformans strain H99 incubation alone (H99), with alveolar macrophages (AM), 
with interstitial macrophages (IM), with Ly6c- monocyte-like macrophages (Ly6c-) and Ly6c+ 
monocyte-like macrophages (Ly6c+). Inoculum indicates initial C. neoformans strain H99 




populations following incubation with C. neoformans strain H99. Graph (c) shows CFU counts in 
CFU/mL from female phagocyte populations following incubation with C. neoformans strain 
H99. The data are means ± standard errors of the means (SEM) for three independent experiments 
each of both male and female mice each done in triplicate. A two tailed unpaired t test was 
performed with each phagocyte population to compared to cryptococcal growth of the C. 































































































Figure 4. Murine pulmonary dendritic cell subsets exhibit differing anti-cryptococcal 
capabilities dependent upon sex. Pulmonary dendritic cell (DC) subsets were purified from both 




5% CO2 at a ratio of 20:1. DCs were lysed and plated on YPD agar and CFUs were counted. 
Graph (a) shows CFU counts in CFU/mL from both female and male dendritic cell populations 
following C. neoformans strain H99 incubation alone (H99), with CD11b+ dendritic cells (DC 
CD11b+), and CD103+ dendritic cells (DC CD103+). Inoculum indicates initial C. neoformans 
strain H99 concentration prior to incubation. Graph (b) shows CFU counts in CFU/ml from 
female dendritic cell populations following incubation with C. neoformans strain H99. Graph (c) 
shows CFU counts in CFU/ml from male dendritic cell populations following incubation with C. 
neoformans strain H99. The data are means ± standard errors of the means (SEM) for three 
independent experiments of each sex. A two tailed unpaired t test was performed with each DC 
population compared to cryptococcal growth of the C. neoformans H99 control group. Significant 
differences (*) shown in graph (b) represent a p < 0 .05. 
 
3.2 Murine pulmonary phagocyte subsets interact with C. neoformans 
In order to verify that C. neoformans interacted with murine pulmonary phagocyte subsets 
equally (and that any differences in antifungal activity were not attributable to differences in 
interaction), both male and female pulmonary macrophage and DC subsets were incubated with 
an m-cherry expressing C. neoformans strain (KN99mCH) for 2 hours at 37C, 5% CO2 at a ratio 
of 1:1. Following incubation, cells were stained and examined by flow cytometry. When 
analyzing macrophage subsets and C. neoformans association, data showed that all subsets 
interacted with C. neoformans, and there were no significant differences between the populations 
(Figure 5a), even when sexes were stratified (Figure 5b and 5c). When analyzing DC-C. 
neoformans association via flow cytometry, results showed that both DC subsets (CD103+ and 
CD11b+ DCs) interact with C. neoformans (Figure 6a), even when sexes were stratified (Figure 
6b and 6c). These results show that all pulmonary phagocyte subsets have the ability to interact 












Figure 5. Murine pulmonary phagocyte subsets interact with C. neoformans ex vivo. 
Pulmonary macrophage subsets were purified from both male and female BALB/c mice and 
incubated with m-cherry expressing C. neoformans (Kn99mCH) for 2hrs at 37°C, 5% CO2 at a 
ratio of 1:1. Following incubation, cells were stained for surface markers and analyzed for 
cryptococcal association via flow cytometry. Graph (a) shows C. neoformans strain H99 
association percentages (Percentage) for both male and female alveolar macrophage (AM), 
interstitial macrophage (IM), Ly6c- monocyte-like macrophages (Ly6c-) and Ly6c+ monocyte-like 
macrophages (Ly6c+) phagocyte populations. Graph (b) shows C. neoformans strain H99 
association percentages (Percentage) for male phagocyte populations. Graph (c) shows C. 
neoformans strain H99 association percentages (Percentage) for female phagocyte populations. 
The data are means ± standard errors of the means (SEM) for three independent experiments each 






















Figure 6. Murine pulmonary dendritic cell subsets interact with C. neoformans ex vivo. 
Pulmonary dendritic cells (DCs) were purified from both male and female BALB/c mice and 
incubated with m-cherry expressing C. neoformans (KN99mCH) for 2hrs at 37°C, 5% CO2 at a 
ratio of 1:1. Following incubation, cells were stained for surface markers and analyzed for 
association via flow cytometry. Graph (a) shows C. neoformans strain H99 association 
percentages (Percentage) for both male and female CD11b+ and CD103+ dendritic cell 
populations. Graph (b) shows C. neoformans strain H99 association percentages (Percentage) for 
male dendritic cell populations. Graph (c) shows C. neoformans strain H99 association 
percentages (Percentage) for female dendritic cell populations. The data are means ± standard 





































































































3.3 Internalized C. neoformans display varying cryptococcal morphologies when interacting 
with pulmonary phagocyte subsets 
In order to determine the cellular morphology of C. neoformans following the pulmonary 
phagocyte subset interaction, imaging flow cytometry was used. Both male and female 
pulmonary phagocyte subsets were incubated with an m-cherry expressing C. neoformans strain 
(KN99mCH) for 2 hours at 37C, 5% CO2 at ratio of 1:1. Following incubation, cells were 
purified and stained for CD45+ leukocyte marker and cryptococcal morphologies were examined 
at a 40x magnification by the ImageStreamX-Imaging Flow Cytometer-MKII (Luminex). Figures 
7a-7f and Figures 8a-8f show examples of intracellular cryptococcal morphologies of 
cryptococcal cells within both male and female phagocyte populations, respectively. Using 
IDEAS 6.2 software (Luminex), images were analyzed and varying cryptococcal morphologies 
were examined and quantified as described in Materials and Methods. Figure 7g and Figure 8g 
show a graphical representation of this quantitative analysis using GraphPad prism. Both male 
and female phagocyte subset populations contain varying intracellular cryptococcal morphologies 
and fungicidal activity as quantified in Figures 7g and 8g.  Figure 7a-7f and Figure 8a-8f show 
distinct cryptococcal morphologies including circular, crescent-shaped (c-shaped), budding and 
debris.  A circular and budding cryptococcal morphology is indicative of living and/or replicating 
cryptococcal yeast cells. The crescent-shaped morphology indicates dead and/or dying 
cryptococcal yeast cells. Structural changes in the cell membrane of live C. neoformans from 
circular to a crescent shaped morphology due to the rupturing of the cell wall is a possible 
indication of cryptococcal death (Camaron R. Hole, Bui, Wormley, & Wozniak, 2012). Data 
revealed female phagocyte sub-populations display varying intracellular cryptococcal 
morphologies upon uptake of the m-cherry-expressing C. neoformans strain (Figure 8a-8f). 
Quantitative analysis of the images from female phagocytes showed that Ly6c- monocyte-like 




In addition, there were significant differences in intracellular cryptococcal morphology 
(condensed and debris) when comparing the alveolar macrophages with both interstitial 
macrophages and CD103+ DCs. The CD103+ DCs showed significant differences intracellular 
cryptococcal morphology when compared to the following subsets – alveolar macrophages, 
interstitial macrophages, Ly6c- monocyte-like macrophages, and CD11b+ DCs. (Figure 8g).   
There were no significant differences found when comparing the male intracellular cryptococcal 

































Figure 7. Murine pulmonary male phagocyte subsets display varying cryptococcal 
morphologies after C. neformans internalization. Using male BALB/c mice, phagocyte subsets 
were purified and incubated with m-cherry expressing C. neoformans (KN99Mch) for 2hrs at a 
ratio of 20:1. Following incubation, cells were stained for surface markers visualized at 40x 
magnification by the ImageStreamX-Imaging Flow Cytometer-MKII (Luminex). Figure 7a-7f 
display cryptococcal morphologies within each pulmonary phagocyte subset. Data of 
cryptoccocal morphology was quantified using IDEAS Software 6.2 and graphically expressed 
using GraphPad Prism (7g). The data are means ± standard errors of the means (SEM) for three 
independent experiments. One-way ANOVA with Tukey’s post-test was used to detect significant 


















































































Figure 8. Murine pulmonary female phagocyte subsets display varying cryptococcal 
morphologies after C. neformans internalization. Using female BALB/c mice, phagocyte 
subsets were purified and incubated with m-cherry expressing C. neoformans (KN99mCH) for 
2hrs at 37°C, 5% CO2 at a ratio of 20:1. Following incubation, cells were stained for surface 
markers visualized at 40x magnification by the ImageStreamX-Imaging Flow Cytometer-MKII 
(Luminex). Figure 8a-8f display cryptococcal morphologies within each pulmonary phagocyte 
subset. Data of cryptococcal morphology were quantified using IDEAS Software 6.2 and 
graphically expressed using GraphPad Prism (8g). The data are means ± standard errors of the 
means (SEM) for three independent experiments. One-way ANOVA with Tukey’s post-test was 
used to detect statistical differences (*,**,***) between groups, p < 0.05,0.01,0.001, respectively. 
3.4 Murine phagocyte fungicidal activity is not dependent upon phagocyte polarization 
In order to determine if exposure to C. neoformans induced polarization of macrophage or DC 
subsets following cryptococcal exposure, cytokine production was examined. Following a 2-hour 
incubation with C. neoformans, cytokines present in the supernatants were assayed using the Bio-
Plex Pro Mouse Cytokine 23-plex (BioRad). Detected (Th1/Th2, pro-inflammatory, chemokine) 
cytokine levels from each subset were quantified as shown in figure 9. Cytokine and chemokine 
levels were tested for both male and female pulmonary phagocyte subset populations alone and 
Debris p < .05 
IM- Ly6c-: *** 
Ly6c+ - Ly6c-: * 
Ly6c- - CD103: ** 
  
  
Condensed p < .05 
AM – IM: * 
AM – CD103: ** 
IM – CD103: * 
Ly6c- - CD103: * 







when incubated with C. neoformans strain H99. When analyzing Th1/Th2 associated cytokine 
levels (Il-12p70, IFN-, IL-13), neither male nor female phagocyte subsets displayed any 
significant differences when comparing the phagocyte population alone and when incubated with 
C. neoformans strain H99 as shown in figure 9a and figure 9b. Next, when analyzing pro-
inflammatory cytokines (IL-1a, TNF-α) male phagocyte subsets did not displayed any significant 
differences in secretion when comparing phagocyte populations alone and when incubated with 
C. neoformans strain H99 (figure 9c). When analyzing female phagocyte subset populations there 
was a significant decrease in the amount of IL-1a secretion when comparing the alveolar 
macrophage population alone to alveolar macrophages when incubated with C. neoformans strain 
H99 (figure 9d). Lastly, when analyzing chemokines (MIP-1α, MCP-1) neither male nor female 
phagocyte subset populations displayed any significant differences in secretion when comparting 
phagocyte populations alone and when incubated with C. neoformans strain H99 as shown in 
figure 9e and figure 9f. The results indicate that phagocyte polarization is not responsible for the 
differences in fungicidal activity exhibited by pulmonary macrophage and dendritic cell 







































































































































































































































































































































































































































































































































































Figure 9. Pulmonary phagocyte cytokine production following incubation with C. 
neoformans. Murine pulmonary macrophages and DCs were harvested and purified using 
magnetic separation. Cell subsets were incubated at a 20:1 ratio with C. neoformans for 2h at 
37°C, 5% CO2 then supernatants were collected. Samples were treated with protease inhibitor and 
frozen at -80C until analysis. Samples were analyzed for cytokines/chemokines by Bioplex. 
Graph (a) and graph (b) shows Th1/Th2 cytokine secretion in pg/ml from both male and female 
phagocyte subsets alone and when incubated with C. neoformans strain H99, respectively. Graph 




































































































































































































phagocyte subsets alone and when incubated with C. neoformans strain H99, respectively. Graph 
(e) and graph (f) shows chemokine secretion from both male and female phagocyte subsets alone 
and when incubated with C. neoformans strain H99, respectively. Data are shown as pg/ml + 
standard errors of the means (SEM) from 3 independent experiments from male mice and 3 
experiments from female mice. AM = alveolar macrophages, IM = interstitial macrophages, 
LY6N = Ly6c- monocyte-like macrophages, LY6P= Ly6C+ positive monocyte-like macrophages, 
CD11b = CD11b+ dendritic cells, CD103 = CD103+ dendritic cells. * indicates p < 0.05 (subset 
alone compared to subset + H99).  
3.5 RNA sequencing analysis of murine pulmonary phagocytes displayed differences in 
transcriptional profiles within permissive and non-permissive phagocytes 
After identification of phagocyte subsets with different antifungal activity from male and female 
BALB/c mice, we were interested in identifying genes involved in these responses. Following a 
2-hour incubation with C. neoformans, both male and female phagocyte subsets were sequenced 
and gene expression was compared between each phagocyte subset when interacting with C. 
neoformans to each subset alone. Permissive vs non permissive phagocytes were compared to 
identify differentially regulated pathways. As shown in figure 10, using the KEGG Pathway 
database, immune-associated response pathways, cell adhesion molecules and antigen processing 
and presentation, were identified within permissive and non-permissive phagocytes and 
compared. Both CD11b+ DCs from male mice (permissive) and Ly6c- monocyte-like 
macrophages (non-permissive) from female mice shared common immune associated signaling 
pathways that included the cell adhesion molecule pathway and the antigen processing and 
presentation pathway. Within the cell adhesion molecule pathway, gene expression analysis 
revealed a down-regulation in MHC-1 (red) within the CD11b+ DCs from male mice (figure 10a). 
When analyzing the same pathway within Ly6c- monocyte-like macrophages from female mice, 




II (red) and PVRL2 (red) as shown in figure 10c. In the antigen processing and presentation 
pathway, within CD11b+ DCs from male mice, there was a down regulation in both MHC-I (red) 
and CALR (red) as shown in figure 10b. When analyzing the same pathway within female mice, 
there was an upregulation in MHC-I (blue) and a down-regulation in both MHC-II (red) and 
HLA-DM (red) as shown in figure 10d. Notably, within both shared pathways, MHC-I was 
significantly down-regulated (p < 0.05) within the permissive CD11b+ DC subsets from male 
mice and significantly up-regulated (p < 0.05) within Ly6c- monocyte-like macrophage subset 
from female mice. Using Ingenuity Pathway Analysis (IPA) software, top canonical (active) 
pathways associated with cell metabolism were predicted and their associated genes were 
identified for both permissive and non-permissive phagocyte subsets as shown in figure 11 and 
figure 13. Within permissive phagocytes, five top canonical (active) metabolic pathways were 
identified that included Acetone Degradation I (to Methylglyoxcal) (p=1.25E-03), Nicotine 
Degradation II (p=8.60E-03), Bupropion Degradation (p=1.21E-02), Uracil Degradation II 
(reductive) (p=2.28E-02), and Thymine Degradation (p=2.28E-02) as shown in figure 11. Within 
these 5 metabolic pathways, their genes associated within permissive phagocytes were identified 
along with their up-regulation or down-regulation (+/-) (figure 11). Within non-permissive 
phagocytes, the top 5 canonical (active) metabolic pathways that were identified included, Netrin 
Signaling (p=3.3E-03), Neuroprotective Role of THOP1 in Alzheimer’s Disease (p=4.31E-03), 
MIF-mediated Glycocorticoid Regulation (p=6.50E-03), Retinoate Biosynthesis I (p=6.50E-03), and 
the Apelin Muscle Signaling Pathway (p=8.02E-03) as shown in figure 13. The specific genes 
within each of these pathways associated with non-permissive phagocytes were also identified 
along with their up-regulation or down-regulation (+/-) (figure 13). Within the Ingenuity Pathway 
Analysis platform, a broader analysis was completed in order to identify over lapping canonical 
pathways based upon shared significantly differentiated genes within permissive and non-
permissive phagocyte subsets (figure 12 and figure 14). Within permissive phagocytes, 25 active 




pathways with shared genes. Figure 12 shows a network of associated metabolic pathways, within 
permissive phagocytes, based upon shared genes. The most active pathways are ranked from p-
values smallest to largest indicated by dark red to light red shading. Within this network the most 
active pathways, shown in dark red, are Acetone Degradation I (to Methylglyoxal), Nicotine 
Degradation II, and Bupropion Degradation including lines connecting each pathway to related 
pathways that have shared genes. Similarly, within non-permissive phagocytes, 25 active 
metabolic pathways were identified as shown in figure 14. Lines connecting pathways represent 
metabolic pathways with shared genes. Figure 14 shows a network of associated metabolic 
pathways within non-permissive phagocytes based upon shared genes. The most active pathways 
are ranked from p-values smallest to largest indicated by dark red to light red shading, 
respectively. Within this network the most active pathways, shown in dark red, are Netrin 
Signaling, Neuroprotective Role of THOP1 in Alzheimer’s Disease, and MIF-mediated 
Glucocorticoid Regulation including lines connecting each pathway to related pathways that have 
shared genes (figure 13). The results indicate the C. neoformans causes distinct transcriptional 






























































Figure 10. Permissive and non-permissive pulmonary phagocytes exhibit transcriptional 
differences in immune associated pathways. Using male and female BALB/c mice, phagocyte 
subsets were purified and incubated with C. neoformans strain H99 at 37C, 5% CO2 for 2hrs at a 
ratio of 20:1. Following incubation, cells were collected and stored in TriZol at -20C until 
analysis. RNA purification and analysis was conducted by Novogene using SMARTer Stranded 
V2 library prep and samples were sequenced using the Illumina Platform. Differential expression 
analysis was compared between each macrophage and DC subset alone and when incubated with 
C. neoformans strain H99. Significant differences within gene expression were identified and 
grouped into signaling pathways using KEGG Pathway Analysis. Figure (a) and figure (b) shows 
the up-regulation and down-regulation of genes associated with male CD11b+ dendritic cells 





pathways, respectively. Figure (c) and figure (d) shows the up-regulation and down-regulation of 
genes associated with female Ly6c- monocyte-like macrophages within the cell adhesion 
molecules and antigen processing and presentation signaling pathways, respectively. Blue and red 
represent genes up-regulated or down-regulated, respectively, in CD11b+ DCs and Ly6c- 
monocyte-like macrophages interacting with C. neoformans compared to the subset alone.  Data 





Figure 11. C. neoformans leads to the activation of highly specific metabolic pathways 
within permissive phagocytes. Using male BALB/c mice, phagocyte subsets were purified and 
incubated with C. neoformans strain H99 at 37C, 5% CO2 for 2hrs at a ratio of 20:1. Following 
incubation, cells were collected and stored in TriZol at -20C until analysis. RNA purification and 
analysis was conducted by Novogene using SMARTer Stranded V2 library prep and samples 
were sequenced using the Illumina Platform. Differential expression analysis was compared 
between each macrophage and DC subset alone and when incubated with C. neoformans strain 
H99. Significant differences within gene expression were identified and grouped into predicted 
canonical pathways using Ingenuity Pathway Analysis (IPA) software. The data show the top five 
active canonical pathways when comparing male CD11b
+




CD11b+ DCs alone in addition to the specific genes involved within each pathway as shown 
below. Data were generated from 1 independent male mice experiment. 
 
 
Figure 12. C. neoformans leads to a highly differentiated network of associated metabolic 
pathways within permissive phagocytes. Using male BALB/c mice, phagocyte subsets were 
purified and incubated with C. neoformans strain H99 at 37C, 5% CO2 for 2hrs at a ratio of 20:1. 
Following incubation, cells were collected and stored in TriZol at -20C until analysis. RNA 
purification and analysis was conducted by Novogene using SMARTer Stranded V2 library prep 
and samples were sequenced using the Illumina Platform. Differential expression analysis was 
compared between each macrophage and DC subset alone and when incubated with C. 




grouped into predicted canonical (active) pathways using Ingenuity Pathway Analysis (IPA) 
software. Associated pathways containing overlapping genes are shown when comparing male 
CD11b+ DCs interacting with C. neoformans to CD11b+ DCs alone. Boxes shaded from dark red 
to light red indicate a difference p < 0.05 from greatest to least, respectively. Connecting lines 






Figure 13. C. neoformans leads to the activation of highly specific metabolic pathways 
within non-permssive phagocytes. Using female BALB/c mice, phagocyte subsets were purified 
and incubated with C. neoformans strain H99 at 37C, 5% CO2 for 2hrs at a ratio of 20:1. 
Following incubation, cells were collected and stored in TriZol at -20C until analysis. RNA 
purification and analysis was conducted by Novogene using SMARTer Stranded V2 library prep 
and samples were sequenced using the Illumina Platform. Differential expression analysis was 
compared between each macrophage and DC subset alone and when incubated with C. 




grouped into predicted canonical pathways using Ingenuity Pathway Analysis (IPA) software. Fig 
10a shows the top five active canonical pathways when comparing female Ly6c
-
 monocytes 
interacting with C. neoformans to Ly6c
-
 monocytes alone. Fig 10b shows specific genes that 
associated within each pathway. Data were generated from 2 independent female mice 
experiments.  
 
Figure 14. C. neoformans leads to a differentiated network of associated metabolic pathways 
within non-permissive phagocytes. Using male BALB/c mice, phagocyte subsets were purified 
and incubated with C. neoformans strain H99 at 37C, 5% CO2 for 2hrs at a ratio of 20:1. 
Following incubation, cells were collected and stored in TriZol at -20C until analysis. RNA 




and samples were sequenced using the Illumina Platform. Differential expression analysis was 
compared between each macrophage and DC subset alone and when incubated with C. 
neoformans strain H99. Significant differences within gene expression were identified and 
grouped into predicted canonical (active) pathways using Ingenuity Pathway Analysis (IPA) 
software. Associated pathways containing overlapping genes are shown when comparing female 
Ly6c
-
 monocyte-like macrophages interacting with C. neoformans to Ly6c
- 
monocyte-like 
macrophages alone. Connecting lines indicate pathways with shared genes. Boxes shaded from 
dark red to light red indicates a difference p < 0.05 from greatest to least, respectively. Data were 








DISCUSSION AND CONCLUSION 
 
Although the induction of ART therapy has resulted in declining HIV/AIDS related mortality, C. 
neoformans still remains the leading cause of fungal related death in these patients (Rajasingham 
et al., 2017). Due to the intracellular nature of C. neoformans, the identification of specific 
mechanisms that mediate intracellular C. neoformans survival and replication can aid in the 
development of novel therapies for the treatment of cryptococcosis. Previous studies have provided 
an investigation into the intracellular nature of C. neoformans and phagocytic cells using peripheral 
blood mononuclear cells (PBMCs), or macrophage cell lines (De Leon-Rodriguez, Rossi, Fu, 
Dragotakes, Coelho, Guerrero Ros, et al., 2018; Subramani et al., 2020). In addition, more recent 
fate-mapping studies have identified macrophage and DC subsets and have defined origins of both 
human and murine phagocytes (Gordon, Plüddemann, & Martinez Estrada, 2014; Hoffmann et al., 
2018; Misharin, 2013) but few have analyzed how these phagocyte subsets initially interact with 
C. neoformans (reviewed in (Nelson et al., 2020)). The bacterial pathogen, Mycobacterium 
tuberculosis (Mtb) has similar lung pathology, can survive intracellularly in macrophages, and his 




(Pirofski & Casadevall, 2020; Serbina, Jia, Hohl, & Pamer, 2008)). Studies have shown that 
alveolar macrophages are more permissive to intracellular bacterial growth as opposed to interstitial 
macrophages resulting in differences in transcriptional responses  upon the interaction with Mtb 
(Huang, Nazarova, & Russell, 2019; Huang, Nazarova, Tan, Liu, & Russell, 2018; Pisu, Huang, 
Grenier, & Russell, 2020).  
In our study, we first examined the fungicidal activity of each murine pulmonary phagocyte subsets. 
We demonstrated that pulmonary phagocyte subsets respond differently upon interaction with C. 
neoformans. Additionally, it has been observed that males are more affected by C. neformans 
related infection more frequently and more severely than females (as reviewed in (Guess, Rosen, 
& McClelland, 2018). Furthermore, the requirement to study sex as a biological variable led us to 
conduct these experiments in both male and female mice. We then noticed differences in data 
generated from male mice compared to female mice, which led to the further examination of our 
data through stratification by sex. Once our data was stratified by sex, results showed a significant 
decrease in the amount of cryptococcal growth when C. neoformans strain H99 was incubated with 
female Ly6c- monocyte-like macrophages as compared to the H99 control. However, this was not 
seen within the male phagocyte population. In a reversible hepatic fibrosis murine model, it was 
shown that Ly6c- monocyte like-macrophages played a crucial role in resolving inflammation and 
showed an enrichment for pathways related to lysosomes, endocytosis and antigen presentation 
which are implicated in phagocytosis (Butenko et al., 2020; Ramachandran et al., 2012). Female 




inflammation and controlling cryptococcal growth during a C. neoformans infection. Based on 
these results several studies were initiated to confirm these findings and to gain more insight into 
the C. neoformans and pulmonary phagocyte interaction.  
In our studies, an association analysis was performed with the use of flow cytometry in order to 
verify that each pulmonary phagocyte subset was able to interact with C. neoformans, and that our 
antifungal activity was not biased by the lack of interaction by individual subsets. We confirmed 
that all murine pulmonary phagocyte subsets interacted with C. neoformans ex vivo to a similar 
degree. Therefore, our differences in antifungal activity were not attributable to differences in 
degree of phagocyte-cryptococcal interactions. To our knowledge, we are the first to examine each 
specific pulmonary phagocyte subset to determine their individual interactions with C. neoformans, 
and we are also the first to observe sex differences in pulmonary phagocyte antifungal activity.  
To observe early pulmonary phagocyte-cryptococcal interaction, we conducted an imaging flow 
cytometric analysis. This technology allowed us to quantify intracellular morphologies within each 
subset. We did not observe significant differences in fungicidal activity in phagocytes from male 
mice. However, these data are from a 2 hr interaction, and as evidenced by our 24hr antifungal 
assays, these phenotypes change over the course of the incubation period.  
Previous literature has shown that phagocyte polarization phagocyte polarization (specifically 
macrophage polarization) is critical for controlling cryptococcal infection. Protective responses in 
a murine vaccination model are highly dependent upon cell mediated Th1-type immune responses 




2009). Permissive growth of C. neoformans is related to the induction of a Th2-type response, 
leading to the induction of M2 macrophage polarization and disease exacerbation (Müller et al., 
2008; Osterholzer, Surana, et al., 2009). In our study we performed a cytokine analysis using each 
pulmonary phagocyte subset in order to identify possible phagocyte polarization. In cells from both 
male and female mice, we did not observe any significant decreases in the amount of secreted 
Th1/Th2 associated cytokines IL-12p40, IL-13, and IFN-γ or chemokines MIP-1a and MCP-1 
when comparing phagocyte subsets alone and when incubated with C. neoformans strain H99. 
Similarly, when observing pro-inflammatory cytokine secretion of IL-1a and TNF-a there were no 
differences seen in cytokine secretion within the male phagocyte population alone and when 
incubated with C. neoformans strain H99. However, within female mice there was a significant 
decrease in secretion of pro-inflammatory IL-1a when alveolar macrophages were incubated with 
C. neoformans strain H99. Though neither of the other female phagocyte subsets displayed any 
observed differences in IL-1a and TNF-a secretion. Although we did observe some changes in 
overall cytokine production by pulmonary phagocytes, none correlated to polarization of 
macrophages or DCs. Therefore, we concluded that phagocyte polarization is not responsible for 
the differences in antifungal activity observed by some subsets.   
In order to analyze differences within the transcriptional profiles of permissive and non-permissive 
phagocyte subsets, we conducted an RNA sequencing analysis comparing each phagocyte subset 
upon the interaction with C. neoformans to the subset alone. Within permissive and non-permissive 




genes that were significantly up-regulated and down-regulated.  Further studies are needed to 
provide a more in-depth analysis into these pathways in order to determine their involvement in 
regard to fungicidal activity within permissive and non-permissive phagocytes. In addition, within 
the permissive male phagocyte subset CD11b+ DCs we observed a significant down regulation with 
MHC-1 associated with immune response, antigen processing and presentation and cell adhesion 
molecules. Interestingly, this expression greatly contrasted within the non-permissive female Ly6c- 
monocyte-like macrophages which exhibited an upregulation in MHC-1. The major 
histocompatibility (MHC) class 1 antigen presentation pathway plays a vital role in adaptive 
immunity by recognizing and alerting the immune system to virally infected cells as reviewed in 
(Hewitt, 2003). MHC Class I molecules are present on the cell surface of all nucleated cells as 
reviewed in (Muntjewerff, Meesters, Bogaart, & Revelo, 2020) and function to present foreign and 
antigenic peptides primarily to CD8+ T lymphocytes for defense against intracellular pathogens  
(Cruz, Colbert, Merino, Kriegsman, & Rock, 2017; Embgenbroich & Burgdorf, 2018; Wieczorek 
et al., 2017). Evidence that permissive phagocytes show a down-regulation in MHC class I serves 
as indicator that C. neoformans leads to transcriptional changes which may contribute in a 
deficiency in vital immune cell machinery that aids to control and eliminate the fungal pathogen. 
Our pathway analysis, revealed top pathways activated, related to various metabolic functioning, 
within permissive and non-permissive phagocytes. An overlapping pathway analysis was 
conducted in order to identify related pathways based upon differentially expressed gene 
overlapping. The results revealed multiple distinct metabolic pathways linked by common gene 




multiple metabolic pathways. This information can serve as roadmap to target genes that are 
resulting in the difference in fungicidal capabilities within pulmonary murine phagocytes.   
To our knowledge, our studies have provided the first examination of individual phagocyte subset 
interactions with C. neoformans. The results from these studies lead us to conclude that different 
populations of murine pulmonary phagocytes interact differently with C. neoformans, and these 
differences depend upon sex of the murine host and differential gene expression, but are not 
dependent on phagocyte polarization. Future studies using gene knockout mice for pulmonary C. 
neoformans infection will be needed to provide further insight into the functional aspects of genes 
and signaling pathways identified in these studies. This will guide our studies to eventually target 
specific genes/pathways for use to prevent intracellular replication and trafficking of C. neoformans 
to the brain in order to prevent meningitis. The results from this study indicate the need for 
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